UK-based pharmaceutical company with Kansas City presence goes private in $5.6B deal

If finalized, the $5.6 billion deal will affect the company's North American headquarters in Overland Park.
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news